SV2A and Alzheimer disease: As indirect evidence of histopathological changes in the brain, CSF SV2A levels in this study significantly correlated with the cognitive performance of patients with AD and progressively declined with AD progression, which reflects the role of CSF SV2A in the monitoring of AD progression.